Stay updated on Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Locations section now consolidates and lists participating sites by state (Arizona, California, Florida, Iowa, Massachusetts, Minnesota, Mississippi, New York, North Carolina, Ohio, Oregon, Rhode Island, Tennessee, Texas, Virginia). The HHS Vulnerability Disclosure link was removed and the page revision is updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T08:14:57.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:49:45.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and introduced a revision tag labeled v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:39:29.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The funding/operational status notice at the bottom of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:33:24.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The new screenshot shows only formatting and layout tweaks; there are no visible changes to the study data or listed criteria.
    Difference
    0.3%
    Check dated 2025-11-03T01:11:40.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:10:43.000Z thumbnail image

Stay in the know with updates to Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.